Terms ending in 2034
Every in-force patent on AstraZeneca AB's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,889,671 | Compounds and Methods for Treating Bacterial Infections In force · High confidence | Entasis Therapeutics Inc. | In force | High confidence | |
| US 9,187,495 | Compounds and Methods for Treating Bacterial Infections In force · Medium confidence | Entasis Therapeutics Inc. | In force | Medium confidence | |
| US 10,556,939 | GLUCAGON/GLP-1 Agonists for the Treatment of Obesity In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 9,463,200 | Cell-Penetrating Oligonucleotides In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,066,979 | Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,375,432 | Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,718,806 | Quinazoline Inhibitors of Activating Mutant Forms of Epidermal Growth Factor Receptor In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,156,831 | Chemical Compounds In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,098,191 | Antibodies to Amyloid Beta In force · Low confidence | MedImmune Limited | In force | Low confidence | |
| US 9,163,020 | Azaindole Compounds, Synthesis Thereof, and Methods of Using the Same In force · High confidence | Foundation for Neglected Disease Research | In force | High confidence | |
| 11 more term ends in 2034 · Pro | |||||
10 of 21 patents shown. Soonest term end first, then patent number.
Pro members see all 21.
16 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.